PRESTIGE CONSUMER HEALTHCARE INC. Repayments of Long-Term Debt
PRESTIGE CONSUMER HEALTHCARE INC. (PBH) reported Repayments of Long-Term Debt of $0 for the 9-month period ending 2020-12-31, per its 10-Q filed 2021-02-04.
Discontinued › Cash Flow › Financing Activities
us-gaap:RepaymentsOfLongTermDebt · last filed 2021-02-04
- PRESTIGE CONSUMER HEALTHCARE INC. repayments of long-term debt for the quarter ending 2015-12-31 was $0.00, a 100.00% decline year-over-year.
- PRESTIGE CONSUMER HEALTHCARE INC. repayments of long-term debt for the quarter ending 2015-09-30 was $25.00M, a 0.00% change year-over-year.
- PRESTIGE CONSUMER HEALTHCARE INC. repayments of long-term debt for the quarter ending 2015-06-30 was $25.00M.
- PRESTIGE CONSUMER HEALTHCARE INC. repayments of long-term debt for the quarter ending 2014-12-31 was $55.00M, a 60.71% decline year-over-year.
- PRESTIGE CONSUMER HEALTHCARE INC. repayments of long-term debt for fiscal 2014 was $157.50M, a 17.11% decline from fiscal 2013.
- PRESTIGE CONSUMER HEALTHCARE INC. repayments of long-term debt for fiscal 2013 was $190.00M, a 660.00% increase from fiscal 2012.
- PRESTIGE CONSUMER HEALTHCARE INC. repayments of long-term debt for fiscal 2012 was $25.00M, a 51.06% decline from fiscal 2011.
- PRESTIGE CONSUMER HEALTHCARE INC. repayments of long-term debt for fiscal 2011 was $51.09M, a 85.41% decline from fiscal 2010.
| Period end | Repayments of Long-term Debt 3 month | Repayments of Long-term Debt 6 month | Repayments of Long-term Debt 9 month | Repayments of Long-term Debt 12 month |
|---|---|---|---|---|
| 2020-12-31 | $0.00 10-Q · filed 2021-02-04 | |||
| 2019-12-31 | $400.00M 10-Q · filed 2021-02-04 | |||
| 2018-12-31 | $0.00 10-Q · filed 2020-02-06 | |||
| 2015-12-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-02-04 | $25.00M derived: sum of 2 quarters · filed 2016-02-04 | $50.00M 10-Q · filed 2016-02-04 | |
| 2015-09-30 | $25.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-11-05 | $50.00M 10-Q · filed 2015-11-05 | ||
| 2015-06-30 | $25.00M 10-Q · filed 2015-08-06 | |||
| 2014-12-31 | $55.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-02-04 | $80.00M derived: sum of 2 quarters · filed 2016-02-04 | $80.00M 10-Q · filed 2016-02-04 | $90.00M derived: sum of 4 quarters · filed 2016-02-04 |
| 2014-09-30 | $25.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-11-05 | $25.00M 10-Q · filed 2015-11-05 | $35.00M derived: sum of 3 quarters · filed 2015-11-05 | $175.00M derived: sum of 4 quarters · filed 2015-11-05 |
| 2014-06-30 | $0.00 10-Q · filed 2015-08-06 | $10.00M derived: sum of 2 quarters · filed 2015-08-06 | $150.00M derived: sum of 3 quarters · filed 2015-08-06 | $157.50M derived: sum of 4 quarters · filed 2015-08-06 |
| 2014-03-31 | $10.00M derived: 10-K 12 month − 10-Q 9 month · filed 2014-05-19 | $150.00M derived: sum of 2 quarters · filed 2015-02-05 | $157.50M derived: sum of 3 quarters · filed 2015-02-05 | $157.50M 10-K · filed 2014-05-19 |
| 2013-12-31 | $140.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-02-05 | $147.50M derived: sum of 2 quarters · filed 2015-02-05 | $147.50M 10-Q · filed 2015-02-05 | $170.00M derived: sum of 4 quarters · filed 2015-02-05 |
| 2013-09-30 | $7.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-11-06 | $7.50M 10-Q · filed 2014-11-06 | $30.00M derived: sum of 3 quarters · filed 2014-11-06 | $127.50M derived: sum of 4 quarters · filed 2014-11-06 |
| 2013-06-30 | $0.00 10-Q · filed 2013-08-01 | $22.50M derived: sum of 2 quarters · filed 2014-05-19 | $120.00M derived: sum of 3 quarters · filed 2014-05-19 | $145.00M derived: sum of 4 quarters · filed 2014-05-19 |
| 2013-03-31 | $22.50M derived: 10-K 12 month − 10-Q 9 month · filed 2014-05-19 | $120.00M derived: sum of 2 quarters · filed 2014-05-19 | $145.00M derived: sum of 3 quarters · filed 2014-05-19 | $190.00M 10-K · filed 2014-05-19 |
| 2012-12-31 | $97.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-02-07 | $122.50M derived: sum of 2 quarters · filed 2014-02-07 | $167.50M 10-Q · filed 2014-02-07 | $134.50M derived: sum of 4 quarters · filed 2014-05-19 |
| 2012-09-30 | $25.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-11-07 | $70.00M 10-Q · filed 2013-11-07 | $37.00M derived: sum of 3 quarters · filed 2014-05-19 | $55.00M derived: sum of 4 quarters · filed 2014-05-19 |
| 2012-06-30 | $45.00M 10-Q · filed 2013-08-01 | $12.00M derived: sum of 2 quarters · filed 2014-05-19 | $30.00M derived: sum of 3 quarters · filed 2014-05-19 | $47.00M derived: sum of 4 quarters · filed 2014-05-19 |
| 2012-03-31 | -$33.00M derived: 10-K 12 month − 10-Q 9 month · filed 2014-05-19 | -$15.00M derived: sum of 2 quarters · filed 2014-05-19 | $2.00M derived: sum of 3 quarters · filed 2014-05-19 | $25.00M 10-K · filed 2014-05-19 |
| 2011-12-31 | $18.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-02-07 | $35.00M derived: sum of 2 quarters · filed 2013-02-07 | $58.00M 10-Q · filed 2013-02-07 | $75.50M derived: sum of 4 quarters · filed 2013-05-17 |
| 2011-09-30 | $17.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-11-07 | $40.00M 10-Q · filed 2012-11-07 | $57.50M derived: sum of 3 quarters · filed 2013-05-17 | $58.50M derived: sum of 4 quarters · filed 2013-05-17 |
| 2011-06-30 | $23.00M 10-Q · filed 2012-08-09 | $40.50M derived: sum of 2 quarters · filed 2013-05-17 | $41.50M derived: sum of 3 quarters · filed 2013-05-17 | $45.63M derived: sum of 4 quarters · filed 2013-05-17 |
| 2011-03-31 | $17.50M derived: 10-K 12 month − 10-Q 9 month · filed 2013-05-17 | $18.50M derived: sum of 2 quarters · filed 2013-05-17 | $22.63M derived: sum of 3 quarters · filed 2013-05-17 | $51.09M 10-K · filed 2013-05-17 |
| 2010-12-31 | $1.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-02-09 | $5.13M derived: sum of 2 quarters · filed 2012-02-09 | $33.59M 10-Q · filed 2012-02-09 | |
| 2010-09-30 | $4.13M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-11-09 | $32.59M 10-Q · filed 2011-11-09 | ||
| 2010-06-30 | $28.46M 10-Q · filed 2011-08-05 | |||
| 2010-03-31 | $350.25M 10-K · filed 2012-05-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 | |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |